Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510)

NeuroImage

Volumn 54, Issue 4, 2011, Pages 2652-2658

  Yang, Dewen ^a   Xie, Zhiyong ^a   Stephenson, Diane ^a   Morton, Daniel ^a   Hicks, Carol D ^a   Brown, Tracy M ^a   Sriram, Renuka ^a   O'Neill, Sharon ^a   Raunig, David ^a   Bocan, Thomas ^a  

^a PFIZER INC   (United States)

Author keywords

Alzheimer's disease; MRI; MRS; Tau; Transgenic mice

Indexed keywords

CREATINE; INOSITOL; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN SIZE; CELL LOSS; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEASIBILITY STUDY; FEMALE; GLIOSIS; HIPPOCAMPUS; HISTOPATHOLOGY; IMAGE QUALITY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOUSE; NERVE CELL; NERVE STIMULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTON NUCLEAR MAGNETIC RESONANCE; TAUOPATHY; TRANSGENIC MOUSE; VOLUMETRY; WILD TYPE;

ALZHEIMER DISEASE; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, TRANSGENIC; TAU PROTEINS;

EID: 78650930400     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.10.067     Document Type: Article

References (38)

1. Allen B., Ingram E., Takao M., Smith M.J., Jakes R., Virdee K., Yoshida H., Holzer M., Craxton M., Emson P.C., Atzori C., Migheli A., Crowther R.A., Ghetti B., Spillantini M.G., Goedert M. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J. Neurosci. 2002, 22:9340-9351.
2. Alonso A.C., Grundke-Iqbal I., Iqbal K. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med. 1996, 2:783-787.
3. Apostolova L.G., Dutton R.A., Dinov I.D., Hayashi K.M., Toga A.W., Cummings J.L., Thompson P.M. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch. Neurol. 2006, 63:693-699.
4. Ball M.J., Fisman M., Hachinski V., Blume W., Fox A., Kral V.A., Kirshen A.J., Fox H., Merskey H. A new definition of Alzheimer's disease: a hippocampal dementia. Lancet 1985, 1:14-16.
5. Bellucci A., Westwood A.J., Ingram E., Casamenti F., Goedert M., Spillantini M.G. Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein. Am. J. Pathol. 2004, 165:1643-1652.
6. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
7. Devanand D.P., Pradhaban G., Liu X., Khandji A., De Santi S., Segal S., Rusinek H., Pelton G.H., Honig L.S., Mayeux R., Stern Y., Tabert M.H., de Leon M.J. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 2007, 68:828-836.
8. Du A.T., Schuff N., Amend D., Laakso M.P., Hsu Y.Y., Jagust W.J., Yaffe K., Kramer J.H., Reed B., Norman D., Chui H.C., Weiner M.W. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2001, 71:441-447.
9. Fan Y., Batmanghelich N., Clark C.M., Davatzikos C. Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline. Neuroimage 2008, 39:1731-1743.
10. Giannakopoulos P., Herrmann F.R., Bussiere T., Bouras C., Kovari E., Perl D.P., Morrison J.H., Gold G., Hof P.R. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 2003, 60:1495-1500.
11. Ikeda M., Shoji M., Kawarai T., Kawarabayashi T., Matsubara E., Murakami T., Sasaki A., Tomidokoro Y., Ikarashi Y., Kuribara H., Ishiguro K., Hasegawa M., Yen S.H., Chishti M.A., Harigaya Y., Abe K., Okamoto K., St George-Hyslop P., Westaway D. Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice. Am. J. Pathol. 2005, 166:521-531.
12. Jack C.R., Dickson D.W., Parisi J.E., Xu Y.C., Cha R.H., O'Brien P.C., Edland S.D., Smith G.E., Boeve B.F., Tangalos E.G., Kokmen E., Petersen R.C. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 2002, 58:750-757.
13. Kantarci K., Petersen R.C., Boeve B.F., Knopman D.S., Tang-Wai D.F., O'Brien P.C., Weigand S.D., Edland S.D., Smith G.E., Ivnik R.J., Ferman T.J., Tangalos E.G., Jack C.R. 1H MR spectroscopy in common dementias. Neurology 2004, 63:1393-1398.
14. Keene O.N. The log transformation is special. Stat. Med. 1995, 14:811-819.
15. Killiany R.J., Hyman B.T., Gomez-Isla T., Moss M.B., Kikinis R., Jolesz F., Tanzi R., Jones K., Albert M.S. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology 2002, 58:1188-1196.
16. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., Bergstrom M., Savitcheva I., Huang G.F., Estrada S., Ausen B., Debnath M.L., Barletta J., Price J.C., Sandell J., Lopresti B.J., Wall A., Koivisto P., Antoni G., Mathis C.A., Langstrom B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 2004, 55:306-319.
17. Kudo Y., Okamura N., Furumoto S., Tashiro M., Furukawa K., Maruyama M., Itoh M., Iwata R., Yanai K., Arai H. 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients. J. Nucl. Med. 2007, 48:553-561.
18. Lau J.C., Lerch J.P., Sled J.G., Henkelman R.M., Evans A.C., Bedell B.J. Longitudinal neuroanatomical changes determined by deformation-based morphometry in a mouse model of Alzheimer's disease. Neuroimage 2008, 42:19-27.
19. Lewis J., McGowan E., Rockwood J., Melrose H., Nacharaju P., Van Slegtenhorst M., Gwinn-Hardy K., Paul Murphy M., Baker M., Yu X., Duff K., Hardy J., Corral A., Lin W.L., Yen S.H., Dickson D.W., Davies P., Hutton M. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 2000, 25:402-405.
20. Littell R.C., Milliken G.A., Stroup W.W., Wolfinger R.D., Schabenberger O. SAS for Mixed Models, Second Version 2006, 754-756. SAS Publishing, Cary, NC.
21. Maheswaran S., Barjat H., Rueckert D., Bate S.T., Howlett D.R., Tilling L., Smart S.C., Pohlmann A., Richardson J.C., Hartkens T., Hill D.L., Upton N., Hajnal J.V., James M.F. Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRI. Brain Res. 2009, 1270:19-32.
22. Marjanska M., Curran G.L., Wengenack T.M., Henry P.G., Bliss R.L., Poduslo J.F., Jack C.R., Ugurbil K., Garwood M. Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc. Natl Acad. Sci. USA 2005, 102:11906-11910.
23. McDaniel B., Sheng H., Warner D.S., Hedlund L.W., Benveniste H. Tracking brain volume changes in C57BL/6J and ApoE-deficient mice in a model of neurodegeneration: a 5-week longitudinal micro-MRI study. Neuroimage 2001, 14:1244-1255.
24. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 1993, 30:672-679.
25. Ramsden M., Kotilinek L., Forster C., Paulson J., McGowan E., SantaCruz K., Guimaraes A., Yue M., Lewis J., Carlson G., Hutton M., Ashe K.H. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J. Neurosci. 2005, 25:10637-10647.
26. Sankoh A.J., Huque M.F., Dubey S.D. Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat. Med. 1997, 16:2529-2542.
27. Santacruz K., Lewis J., Spires T., Paulson J., Kotilinek L., Ingelsson M., Guimaraes A., DeTure M., Ramsden M., McGowan E., Forster C., Yue M., Orne J., Janus C., Mariash A., Kuskowski M., Hyman B., Hutton M., Ashe K.H. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005, 309:476-481.
28. Skovronsky D.M., Lee V.M., Trojanowski J.Q. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu. Rev. Pathol. 2006, 1:151-170.
29. Small G.W., Kepe V., Ercoli L.M., Siddarth P., Bookheimer S.Y., Miller K.J., Lavretsky H., Burggren A.C., Cole G.M., Vinters H.V., Thompson P.M., Huang S.C., Satyamurthy N., Phelps M.E., Barrio J.R. PET of brain amyloid and tau in mild cognitive impairment. N Engl J. Med. 2006, 355:2652-2663.
30. Spires T.L., Orne J.D., SantaCruz K., Pitstick R., Carlson G.A., Ashe K.H., Hyman B.T. Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Am. J. Pathol. 2006, 168:1598-1607.
31. Wang J., Tanila H., Puolivali J., Kadish I., van Groen T. Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice. Neurobiol. Dis. 2003, 14:318-327.
32. Webster B., Hansen L., Adame A., Crews L., Torrance M., Thal L., Masliah E. Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease. J. Neuropathol. Exp. Neurol. 2006, 65:142-151.
33. Weiss C., Venkatasubramanian P.N., Aguado A.S., Power J.M., Tom B.C., Li L., Chen K.S., Disterhoft J.F., Wyrwicz A.M. Impaired eyeblink conditioning and decreased hippocampal volume in PDAPP V717F mice. Neurobiol. Dis. 2002, 11:425-433.
34. Whitwell J.L., Shiung M.M., Przybelski S.A., Weigand S.D., Knopman D.S., Boeve B.F., Petersen R.C., Jack C.R. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology 2008, 70:512-520.
35. Xie Z., Ng L., Gee J.C. Two algorithms for non-rigid image registration and their evaluation. Proc. SPIE; Medical Imaging 2003: Image Processing San Diego, CA, USA 2003, 157.
36. Yoshiyama Y., Higuchi M., Zhang B., Huang S.M., Iwata N., Saido T.C., Maeda J., Suhara T., Trojanowski J.Q., Lee V.M. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007, 53:337-351.
37. Yue, M., Hanna, A., Wilson, J., Roder, H., Janus, C., 2009. Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy. Neurobiol. Aging. http://doi:10.1016/j.neurobiolaging.2009.04.006.
38. Yushkevich P.A., Piven J., Hazlett H.C., Smith R.G., Ho S., Gee J.C., Gerig G. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 2006, 31:1116-1128.